You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Development of a Neutron-based Nondestructive Test Method for Concrete Petrography and Chemical Analysis
SBC: TOURNEY CONSULTING GROUP, LLC Topic: NoneTo evaluate the technical feasibility of prompt gamma neutron activation (PGAA) as an alternative to a set of standard destructive tests of concrete petrography including aggregate type, water/cement ratio, aggregate/binder ratio, density, chloride content and chloride bulk diffusion constant; and to determine the specifications for the design of a dedicated commercial laboratory-based PGAA facili ...
SBIR Phase I 2019 Department of CommerceNational Institute of Standards and Technology -
Nanomachine Device for Semiconductor Process Control Monitoring
SBC: XALLENT INC. Topic: NoneConventional characterization and test methods are increasingly ineffective when applied to structures less than 100 nanometers, causing challenges across R&D, process control and failure analysis. An increasing number of subtle defects become prominent drivers of failure as device size and operating margins decrease, e.g., processing anomalies in thin gate oxides, substrate problems related to do ...
SBIR Phase I 2019 Department of CommerceNational Institute of Standards and Technology -
In Situ Production of Biocidal Reactive Oxygen via Directed Energy
SBC: Zeteo Tech, Inc. Topic: NonDoDThis effort will expand the universe of direct energy enhancers across a wider spectrum of RF parameters to produce optimal decontamination at even lower cost. During the course of the Phase II investigation proposed here, initial work will be carried out on the determination of the fundamental mechanism of decontamination of biological materials with an eye toward expanding applicability to chemi ...
SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense -
A Next Generation, High-Precision, Field Drug Detection System
SBC: SensoDX II, LLC Topic: A16AT008The synthetic opioids fentanyl and carfentanil pose an imminent national security threat, given the ease with which they can be obtained, their low lethal doses, and their potential for weaponized use. The purpose of this agreement is to adapt SensoDx’s high-performance miniaturized diagnostics platform based on a programmable bio-nano-chip, with embedded artificial intelligence, to enable U.S. ...
SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense -
Bi-specific Antibodies Targeting Disease Caused by Encephalitic Alphaviruses
SBC: BRHMS LLC Topic: CBD181007Highly pathogenic alphaviruses like VEEV/EEV/WWEEV cause encephalitis in humans and equids. These infections are endemic in wide regions of the developing world. Translational research regarding these pathogens is focused on developing new strategies to detect, treat and ideally protect humans and animals from these infections. Gene-encoded antibodies against alphavirus E1/E2 surface proteins will ...
SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense -
A Tool for Building Semantically Interoperable Specification and Standards
SBC: XSB INC Topic: 9010273RStandards and specifications are widely used in government and industry to define requirements for products and processes and insure interoperability, safety, and quality of industrial and domestic products. Specifications and standards documents almost always cross-reference other standards and specification. Taken together, the web of interdependent standards forms an immensely important knowled ...
SBIR Phase I 2015 Department of CommerceNational Institute of Standards and Technology -
Burkholderia antibody molecules for therapeutics and diagnostics
SBC: BIOO SCIENTIFIC CORPORATION Topic: CBD14105Burkholderia pseudomallei and Burkholderia mallei are highly pathogenic Gram - negative bacteria and the causative agents of melioidosis and glanders, respectively. These infections, which occur in humans and other animals, are endemic is wide regions of the developing world. This Phase II SBIR project will build on the success of our Phase I work, which established methods for generating monoclon ...
SBIR Phase II 2015 Department of DefenseOffice for Chemical and Biological Defense -
High-Throughput Low-Cost Manufacturing of Engineered MRI Contrast Agents
SBC: WEINBERG MEDICAL PHYSICS, INC. Topic: 9010368RScalable manufacturing of micro-engineered MRI contrast agents has the potential to increase the specificity and resolution of imaging techniques, while reducing morbidity. Currently, techniques used for making such particles are expensive and labor intensive. In Phase I, Weinberg Medical Physics will validate techniques for rapid, massively parallel fabrication of microscale contrast agents (incl ...
SBIR Phase I 2015 Department of CommerceNational Institute of Standards and Technology -
High Performance Beam Scanning Using a Resonant Scan Lens
SBC: XSB INC Topic: 9050140TTThe objective of this project is to demonstrate a resonant scan lens (RSL) that increases the uniformity of beam scans projected from resonant optomechanical systems. While resonant optomechanical systems generate high-speed beam scans, large mechanical displacements, and robust operation from miniature form factors, scans projected from such systems lack uniformity across the field-of-view (FOV). ...
SBIR Phase I 2015 Department of CommerceNational Institute of Standards and Technology -
Concurrent identification of Natural Antibiotics-Producing Gene Clusters and Culture Conditions
SBC: Carrera Bioscience Inc. Topic: CBD152004Modern metagenomics studies on diverse microbiomes revealed immense repertoires of potential natural products/antibiotics to be tapped into.However, identifying such secondary metabolites (SMs) directly from a complex microbiome remains rarely successful due to two major technicalchallenges: i) difficulty in dissecting complex microbiome samples and massive metagenomics data, and ii) difficulty in ...
SBIR Phase I 2015 Department of DefenseOffice for Chemical and Biological Defense